Structure and membrane orientation of IAPP in its natively amidated form at physiological pH in a membrane environment.

Human islet amyloid polypeptide is a hormone coexpressed with insulin by pancreatic beta-cells. For reasons not clearly understood, hIAPP aggregates in type II diabetics to form oligomers that interfere with beta-cell function, eventually leading to the loss of insulin production. The cellular membrane catalyzes the formation of amyloid deposits and is a target of amyloid toxicity through disruption of the membrane's structural integrity. Therefore, there is considerable current interest in solving the 3D structure of this peptide in a membrane environment. NMR experiments could not be directly utilized in lipid bilayers due to the rapid aggregation of the peptide. To overcome this difficulty, we have solved the structure of the naturally occurring peptide in detergent micelles at a neutral pH. The structure has an overall kinked helix motif, with residues 7-17 and 21-28 in a helical conformation, and with a 3(10) helix from Gly 33-Asn 35. In addition, the angle between the N- and C-terminal helices is constrained to 85°. The greater helical content of human IAPP in the amidated versus free acid form is likely to play a role in its aggregation and membrane disruptive activity.

[1]  J. Brender,et al.  Role of zinc in human islet amyloid polypeptide aggregation. , 2010, Journal of the American Chemical Society.

[2]  D. Craik,et al.  Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is? , 1998, Biochemistry.

[3]  M. Billeter,et al.  MOLMOL: a program for display and analysis of macromolecular structures. , 1996, Journal of molecular graphics.

[4]  A. Miranker,et al.  Islet amyloid polypeptide: identification of long-range contacts and local order on the fibrillogenesis pathway. , 2001, Journal of molecular biology.

[5]  John R Cort,et al.  Solution state structures of human pancreatic amylin and pramlintide. , 2009, Protein engineering, design & selection : PEDS.

[6]  R. Riek,et al.  3D structure of Alzheimer's amyloid-β(1–42) fibrils , 2005 .

[7]  D. Raleigh,et al.  Analysis of amylin cleavage products provides new insights into the amyloidogenic region of human amylin. , 1999, Journal of molecular biology.

[8]  J. Brender,et al.  Induction of negative curvature as a mechanism of cell toxicity by amyloidogenic peptides: the case of islet amyloid polypeptide. , 2009, Journal of the American Chemical Society.

[9]  J. Brender,et al.  Membrane fragmentation by an amyloidogenic fragment of human Islet Amyloid Polypeptide detected by solid-state NMR spectroscopy of membrane nanotubes. , 2007, Biochimica et biophysica acta.

[10]  P. Amodeo,et al.  Solution structure of human calcitonin in membrane‐mimetic environment: The role of the amphipathic helix , 1998, Proteins.

[11]  D. Raleigh,et al.  Residue-specific, real-time characterization of lag-phase species and fibril growth during amyloid formation: a combined fluorescence and IR study of p-cyanophenylalanine analogs of islet amyloid polypeptide. , 2010, Journal of molecular biology.

[12]  Yuguang Mu,et al.  The Molecular Basis of Distinct Aggregation Pathways of Islet Amyloid Polypeptide* , 2010, The Journal of Biological Chemistry.

[13]  D. Teplow,et al.  Kinetic studies of amyloid beta-protein fibril assembly. Differential effects of alpha-helix stabilization. , 2002, The Journal of biological chemistry.

[14]  Torsten Herrmann,et al.  Protein NMR structure determination with automated NOE assignment using the new software CANDID and the torsion angle dynamics algorithm DYANA. , 2002, Journal of molecular biology.

[15]  W. Scherbaum The role of amylin in the physiology of glycemic control , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[16]  Kevin Hartman,et al.  A single mutation in the nonamyloidogenic region of islet amyloid polypeptide greatly reduces toxicity. , 2008, Biochemistry.

[17]  Richard Leapman,et al.  Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR. , 2007, Biochemistry.

[18]  Miss A.O. Penney (b) , 1974, The New Yale Book of Quotations.

[19]  A. Fisahn,et al.  α-Helix targeting reduces amyloid-β peptide toxicity , 2009, Proceedings of the National Academy of Sciences.

[20]  D. Laurents,et al.  Alzheimer's Aβ40 Studied by NMR at Low pH Reveals That Sodium 4,4-Dimethyl-4-silapentane-1-sulfonate (DSS) Binds and Promotes β-Ball Oligomerization* , 2005, Journal of Biological Chemistry.

[21]  J. Hutton The internal pH and membrane potential of the insulin-secretory granule. , 1982, The Biochemical journal.

[22]  D. Harrison,et al.  The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. , 1999, Diabetes.

[23]  S. Becker,et al.  Molecular-level secondary structure, polymorphism, and dynamics of full-length alpha-synuclein fibrils studied by solid-state NMR. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Juan J de Pablo,et al.  Stable and metastable states of human amylin in solution. , 2010, Biophysical journal.

[25]  Johannes D. Veldhuis,et al.  Human Islet Amyloid Polypeptide Oligomers Disrupt Cell Coupling, Induce Apoptosis, and Impair Insulin Secretion in Isolated Human Islets , 2007, Diabetes.

[26]  D. Moffet,et al.  Selection for nonamyloidogenic mutants of islet amyloid polypeptide (IAPP) identifies an extended region for amyloidogenicity. , 2010, Biochemistry.

[27]  P. Butler,et al.  Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis. , 2008, Endocrine reviews.

[28]  S. Jayasinghe,et al.  Structure of α-Helical Membrane-bound Human Islet Amyloid Polypeptide and Its Implications for Membrane-mediated Misfolding* , 2008, Journal of Biological Chemistry.

[29]  D. Raleigh,et al.  Two-dimensional IR spectroscopy and isotope labeling defines the pathway of amyloid formation with residue-specific resolution , 2009, Proceedings of the National Academy of Sciences.

[30]  Gianluigi Veglia,et al.  Structures of rat and human islet amyloid polypeptide IAPP(1-19) in micelles by NMR spectroscopy. , 2008, Biochemistry.

[31]  P. Tompa Structural disorder in amyloid fibrils: its implication in dynamic interactions of proteins , 2009, The FEBS journal.

[32]  A. Miranker,et al.  Helix stabilization precedes aqueous and bilayer-catalyzed fiber formation in islet amyloid polypeptide. , 2009, Journal of molecular biology.

[33]  C. Dobson,et al.  A toy model for predicting the rate of amyloid formation from unfolded protein. , 2005, Journal of molecular biology.

[34]  D. Raleigh,et al.  A role for helical intermediates in amyloid formation by natively unfolded polypeptides? , 2009, Physical biology.

[35]  J. Hofrichter,et al.  Evidence for a partially structured state of the amylin monomer. , 2009, Biophysical journal.

[36]  Henning Stahlberg,et al.  The fold of α-synuclein fibrils , 2008, Proceedings of the National Academy of Sciences.

[37]  M. Geyer,et al.  NMR Spectroscopic Investigation of Early Events in IAPP Amyloid Fibril Formation , 2009, Chembiochem : a European journal of chemical biology.

[38]  A. Miranker,et al.  Amide inequivalence in the fibrillar assembly of islet amyloid polypeptide. , 2008, Protein engineering, design & selection : PEDS.

[39]  F. Richards,et al.  The chemical shift index: a fast and simple method for the assignment of protein secondary structure through NMR spectroscopy. , 1992, Biochemistry.

[40]  K. Johnson,et al.  An in vitro model of early islet amyloid polypeptide (IAPP) fibrillogenesis using human IAPP-transgenic mouse islets , 2006, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[41]  A. Miranker,et al.  Synthetic alpha-helix mimetics as agonists and antagonists of islet amyloid polypeptide aggregation. , 2010, Angewandte Chemie.

[42]  Joan-Emma Shea,et al.  Human islet amyloid polypeptide monomers form ordered beta-hairpins: a possible direct amyloidogenic precursor. , 2009, Journal of the American Chemical Society.

[43]  D. Raleigh,et al.  Two-dimensional infrared spectroscopy provides evidence of an intermediate in the membrane-catalyzed assembly of diabetic amyloid. , 2009, The journal of physical chemistry. B.

[44]  A J Day,et al.  Molecular and functional characterization of amylin, a peptide associated with type 2 diabetes mellitus. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Sara M. Butterfield,et al.  Amyloidogenic Protein—Membrane Interactions: Mechanistic Insight from Model Systems , 2010 .

[46]  R. Winter,et al.  Effect of pressure on islet amyloid polypeptide aggregation: revealing the polymorphic nature of the fibrillation process. , 2008, Biochemistry.

[47]  A. Bax,et al.  Protein backbone angle restraints from searching a database for chemical shift and sequence homology , 1999, Journal of biomolecular NMR.

[48]  D. Teplow,et al.  Kinetic Studies of Amyloid β-Protein Fibril Assembly , 2002, The Journal of Biological Chemistry.

[49]  Maarten F. M. Engel,et al.  Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane , 2008, Proceedings of the National Academy of Sciences.

[50]  Kevin Hartman,et al.  Three-dimensional structure and orientation of rat islet amyloid polypeptide protein in a membrane environment by solution NMR spectroscopy. , 2009, Journal of the American Chemical Society.

[51]  A. Miranker,et al.  Phospholipid catalysis of diabetic amyloid assembly. , 2004, Journal of molecular biology.

[52]  S. Jayasinghe,et al.  Membrane interaction of islet amyloid polypeptide. , 2007, Biochimica et biophysica acta.

[53]  R. Riek,et al.  3D structure of Alzheimer's amyloid-beta(1-42) fibrils. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[54]  Maarten F. M. Engel,et al.  Islet amyloid polypeptide‐induced membrane leakage involves uptake of lipids by forming amyloid fibers , 2004, FEBS letters.

[55]  Ad Bax,et al.  Structure and Dynamics of Micelle-bound Human α-Synuclein* , 2005, Journal of Biological Chemistry.

[56]  J. Brender,et al.  Amyloid fiber formation and membrane disruption are separate processes localized in two distinct regions of IAPP, the type-2-diabetes-related peptide. , 2008, Journal of the American Chemical Society.

[57]  Yogendra Pratap Singh,et al.  Amyloid peptides and proteins in review. , 2007, Reviews of physiology, biochemistry and pharmacology.

[58]  J. Brender,et al.  Association of highly compact type II diabetes related islet amyloid polypeptide intermediate species at physiological temperature revealed by diffusion NMR spectroscopy. , 2009, Journal of the American Chemical Society.

[59]  A. Alexandrescu,et al.  Dynamic α-Helix Structure of Micelle-bound Human Amylin* , 2009, Journal of Biological Chemistry.

[60]  Gerard J A Kroon,et al.  Amylin proprotein processing generates progressively more amyloidogenic peptides that initially sample the helical state. , 2008, Biochemistry.

[61]  K. Wüthrich NMR of proteins and nucleic acids , 1988 .

[62]  S. Jayasinghe,et al.  Lipid membranes modulate the structure of islet amyloid polypeptide. , 2005, Biochemistry.

[63]  A. Miranker,et al.  Conserved and cooperative assembly of membrane-bound alpha-helical states of islet amyloid polypeptide. , 2006, Biochemistry.

[64]  K. Wüthrich,et al.  Torsion angle dynamics for NMR structure calculation with the new program DYANA. , 1997, Journal of molecular biology.

[65]  U. Aebi,et al.  Human Amylin Oligomer Growth and Fibril Elongation Define Two Distinct Phases in Amyloid Formation* , 2004, Journal of Biological Chemistry.